Cargando…

A Plasma 5-Marker Host Biosignature Identifies Tuberculosis in High and Low Endemic Countries

Background: Several host inflammatory markers have been proposed as biomarkers for diagnosis and treatment response in Tuberculosis (TB), but few studies compare their utility in different demographic, ethnic, and TB endemic settings. Methods: Fifty-four host biomarkers were evaluated in plasma samp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chendi, Bih H., Snyders, Candice I., Tonby, Kristian, Jenum, Synne, Kidd, Martin, Walzl, Gerhard, Chegou, Novel N., Dyrhol-Riise, Anne M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7958880/ https://www.ncbi.nlm.nih.gov/pubmed/33732236 http://dx.doi.org/10.3389/fimmu.2021.608846

Ejemplares similares

Monocytic myeloid‐derived suppressor cells reflect tuberculosis severity and are influenced by cyclooxygenase‐2 inhibitors
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2020)

Application of Cerebrospinal Fluid Host Protein Biosignatures in the Diagnosis of Tuberculous Meningitis in Children from a High Burden Setting
por: Manyelo, Charles M., et al.
Publicado: (2019)

Elevated Levels of Anti-Inflammatory Eicosanoids and Monocyte Heterogeneity in Mycobacterium tuberculosis Infection and Disease
por: Nore, Kristin Grotle, et al.
Publicado: (2020)

Biosignatures: The answer to Tuberculosis diagnosis in children?
por: Goussard, Pierre, et al.
Publicado: (2020)

Potential of Host Serum Protein Biomarkers in the Diagnosis of Tuberculous Meningitis in Children
por: Manyelo, Charles M., et al.
Publicado: (2019)

Cyclooxygenase inhibitors impair CD4 T cell immunity and exacerbate Mycobacterium tuberculosis infection in aerosol-challenged mice
por: Mortensen, Rasmus, et al.
Publicado: (2019)

Distinct serum biosignatures are associated with different tuberculosis treatment outcomes
por: Ronacher, Katharina, et al.
Publicado: (2019)

Serum and cerebrospinal fluid host proteins indicate stroke in children with tuberculous meningitis
por: Manyelo, Charles M., et al.
Publicado: (2021)

Host markers in Quantiferon supernatants differentiate active TB from latent TB infection: preliminary report
por: Chegou, Novel N, et al.
Publicado: (2009)

Candidate Biomarkers to Distinguish Spinal Tuberculosis From Mechanical Back Pain in a Tuberculosis Endemic Setting
por: Mann, Theresa N., et al.
Publicado: (2021)

IP-10 measured by Dry Plasma Spots as biomarker for therapy responses in Mycobacterium Tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2015)

Plasma LOX-Products and Monocyte Signaling Is Reduced by Adjunctive Cyclooxygenase-2 Inhibitor in a Phase I Clinical Trial of Tuberculosis Patients
por: Jøntvedt Jørgensen, Marthe, et al.
Publicado: (2021)

Identification of novel host biomarkers in plasma as candidates for the immunodiagnosis of tuberculosis disease and monitoring of tuberculosis treatment response
por: Jacobs, Ruschca, et al.
Publicado: (2016)

A Phase I/II randomized trial of H56:IC31 vaccination and adjunctive cyclooxygenase-2-inhibitor treatment in tuberculosis patients
por: Jenum, Synne, et al.
Publicado: (2021)

Targeting Tuberculosis and HIV Infection-Specific Regulatory T Cells with MEK/ERK Signaling Pathway Inhibitors
por: Lieske, Nora V., et al.
Publicado: (2015)

Suitability of saliva for Tuberculosis diagnosis: comparing with serum
por: Namuganga, Anna Ritah, et al.
Publicado: (2017)

Diagnostic Potential of Novel Salivary Host Biomarkers as Candidates for the Immunological Diagnosis of Tuberculosis Disease and Monitoring of Tuberculosis Treatment Response
por: Jacobs, Ruschca, et al.
Publicado: (2016)

Utility of Host Markers Detected in Quantiferon Supernatants for the Diagnosis of Tuberculosis in Children in a High-Burden Setting
por: Chegou, Novel N., et al.
Publicado: (2013)

Early dynamics of T helper cell cytokines and T regulatory cells in response to treatment of active Mycobacterium tuberculosis infection
por: Feruglio, S L, et al.
Publicado: (2015)

The COX- inhibitor indomethacin reduces Th1 effector and T regulatory cells in vitro in Mycobacterium tuberculosis infection
por: Tonby, Kristian, et al.
Publicado: (2016)

The gut microbiome in tuberculosis susceptibility and treatment response: guilty or not guilty?
por: Eribo, Osagie A., et al.
Publicado: (2019)

Differential Expression of Host Biomarkers in Saliva and Serum Samples from Individuals with Suspected Pulmonary Tuberculosis
por: Phalane, Khutso G., et al.
Publicado: (2013)

Host blood-based biosignatures for subclinical TB and incipient TB: A prospective study of adult TB household contacts in Southern India
por: Sivakumaran, Dhanasekaran, et al.
Publicado: (2023)

Changes in Host Immune–Endocrine Relationships during Tuberculosis Treatment in Patients with Cured and Failed Treatment Outcomes
por: Kleynhans, Léanie, et al.
Publicado: (2017)

A metabolic biosignature of early response to anti-tuberculosis treatment
por: Mahapatra, Sebabrata, et al.
Publicado: (2014)

Tuberculous Meningitis: Pathogenesis, Immune Responses, Diagnostic Challenges, and the Potential of Biomarker-Based Approaches
por: Manyelo, Charles M., et al.
Publicado: (2021)

Potential of Host Markers Produced by Infection Phase-Dependent Antigen-Stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area
por: Chegou, Novel N., et al.
Publicado: (2012)

Evaluation of Host Serum Protein Biomarkers of Tuberculosis in sub-Saharan Africa
por: Morris, Thomas C., et al.
Publicado: (2021)

Correction: Potential of Host Markers Produced by Infection Phase-Dependent Antigen-Stimulated Cells for the Diagnosis of Tuberculosis in a Highly Endemic Area
por: Chegou, Novel N., et al.
Publicado: (2012)

Diagnosis and follow-up of treatment of latent tuberculosis; the utility of the QuantiFERON-TB Gold In-tube assay in outpatients from a tuberculosis low-endemic country
por: Dyrhol-Riise, Anne M, et al.
Publicado: (2010)

Host Cytokine Responses Induced after Overnight Stimulation with Novel M. tuberculosis Infection Phase-Dependent Antigens Show Promise as Diagnostic Candidates for TB Disease
por: Essone, Paulin N., et al.
Publicado: (2014)

HIV patients with latent tuberculosis living in a low-endemic country do not develop active disease during a 2 year follow-up; a Norwegian prospective multicenter study
por: Pullar, Nadine Durema, et al.
Publicado: (2014)

Cytokine profile in the sputum of subjects with post-tuberculosis airflow obstruction and in those with tobacco related chronic obstructive pulmonary disease
por: Guiedem, Elise, et al.
Publicado: (2020)

Gut microbiota composition during hospitalization is associated with 60-day mortality after severe COVID-19
por: Trøseid, Marius, et al.
Publicado: (2023)

Detection of a combination of serum IgG and IgA antibodies against selected mycobacterial targets provides promising diagnostic signatures for active TB
por: Awoniyi, Dolapo O., et al.
Publicado: (2017)

An Archetypical Model for Engrafting Bacteroides fragilis into Conventional Mice Following Reproducible Antibiotic Conditioning of the Gut Microbiota
por: Eribo, Osagie A., et al.
Publicado: (2023)

The Functional Response of B Cells to Antigenic Stimulation: A Preliminary Report of Latent Tuberculosis
por: du Plessis, Willem J., et al.
Publicado: (2016)

Identification of eight-protein biosignature for diagnosis of tuberculosis
por: Yang, Qianting, et al.
Publicado: (2020)

Headway made towards biosignatures for incipient tuberculosis
por: Scriba, Thomas J, et al.
Publicado: (2020)

Past and Present Approaches to Diagnosis of Active Pulmonary Tuberculosis
por: Namuganga, Anna Ritah, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2ba959pq9jh5sugiki9io1htm0